What is the equity of Accuray this year?
Accuray has equity of 45.08 M USD this year.
Accuray Equity 2024
Accuray Equity
45.08 M USD
Ticker
ARAY
ISIN
US0043971052
WKN
A0MKWM
In 2024, Accuray's equity was 45.08 M USD, a -15.26% increase from the 53.2 M USD equity in the previous year.
Accuray Aktienanalyse
What does Accuray do?
Accuray Inc is a company that was founded in 1990 and is headquartered in Sunnyvale, California. It is a global leader in providing precision solutions for the radiation treatment of cancer and other medical conditions. The company aims to develop revolutionary technologies that offer doctors and patients new treatment options for cancer and other diseases. History: Accuray was founded as a start-up company by a group of scientists who believed that cancer treatment was a crucial problem, with a lack of precision and control compromising the effectiveness of treatment. Therefore, they decided to develop a solution focused on precise, non-invasive radiation therapy. Since then, Accuray has continuously developed and introduced innovative technologies to enable better treatment for patients. Business model: Accuray's business model focuses on the development, sale, and service of radiation therapy products and solutions. The company provides global clinical support to ensure that customers receive the best possible application of Accuray technologies. Accuray primarily generates its revenues through the sale of radiation therapy systems and services. The company has over 800 employees worldwide and operates manufacturing locations in the US and China. Products and solutions: Accuray offers a wide range of products and solutions for clinical radiation therapy. These include the TomoTherapy systems, CyberKnife systems, and Radixact systems. The TomoTherapy systems have been specifically designed for precise and patient-specific radiation therapy applications. The technology enables precise dosage of radiation to tumor cells, protecting the surrounding healthy tissues. The CyberKnife system is used for the treatment of tumors that are difficult to access, such as those in the brain or spine. The robotic technology and precise radiation dosage enhance the effectiveness of treatment. With the Radixact system, Accuray offers a system that provides the latest generation of radiation therapy. The system delivers extremely precise dosages to the tumor while maximizing the preservation of surrounding tissues. Divisions: Accuray is divided into three business segments: Oncology Systems, Radiation Therapy Services, and Research Solutions. - Oncology Systems: Accuray offers the aforementioned TomoTherapy, CyberKnife, and Radixact systems, providing customers with the latest technology to treat various types of cancer. - Radiation Therapy Services: Accuray also provides a wide range of service and support offerings for its customers. These services include training, maintenance, technician support, and customer support. - Research Solutions: Accuray's research division provides academic institutions and research laboratories with access to a variety of technologies and solutions for radiation therapy and cancer research. Conclusion: Accuray has tirelessly worked to develop innovative technologies for radiation therapy, enabling better treatment and quality of life for patients. The company has made significant progress in recent years and now offers a wide range of products and solutions to its customers. Accuray has established itself as a global leader in radiation therapy and continues its success story with continuous research and innovation. Answer: Accuray Inc is a company that specializes in providing precision solutions for radiation treatment of cancer and other medical conditions. It was founded in 1990 and is headquartered in Sunnyvale, California. The company aims to develop innovative technologies that offer patients and doctors new treatment possibilities. Accuray has three divisions: Oncology Systems, Radiation Therapy Services, and Research Solutions. Their products include TomoTherapy, CyberKnife, and Radixact systems. Accuray is a leading global provider of radiation therapy solutions and continues to make advancements in research and innovation. Accuray ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Accuray's Equity
Accuray's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Accuray's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Accuray's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Accuray's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Accuray’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Accuray stock
What was the equity of Accuray compared to the previous year?
The equity of Accuray has increased/decreased by -15.26% decreased compared to the previous year.
What impact does a high equity have on investors of Accuray?
A high equity is advantageous for investors of Accuray as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Accuray?
A low equity can be a risk for investors of Accuray, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Accuray affect the company?
An increase in equity of Accuray can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Accuray affect the company?
A reduction in equity of Accuray can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Accuray?
Some factors that can affect the equity of Accuray include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Accuray so important for investors?
The equity of Accuray is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Accuray take to change the equity?
To change equity, Accuray can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Accuray pay?
Over the past 12 months, Accuray paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Accuray is expected to pay a dividend of 0 USD.
What is the dividend yield of Accuray?
The current dividend yield of Accuray is .
When does Accuray pay dividends?
Accuray pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Accuray?
Accuray paid dividends every year for the past 0 years.
What is the dividend of Accuray?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Accuray located?
Accuray is assigned to the 'Health' sector.
Wann musste ich die Aktien von Accuray kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Accuray from 12/12/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/12/2024.
When did Accuray pay the last dividend?
The last dividend was paid out on 12/12/2024.
What was the dividend of Accuray in the year 2023?
In the year 2023, Accuray distributed 0 USD as dividends.
In which currency does Accuray pay out the dividend?
The dividends of Accuray are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Accuray stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Accuray
Our stock analysis for Accuray Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Accuray Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
